Previous 10 | Next 10 |
home / stock / acxp / acxp articles
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally broadcasted TV show, announces episode 543, airing o...
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) released Phase 2b results showing 100% of C. difficile Infection (CDI) patients who had cli...
NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally televised business show, announces episode 537, air...
NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- New to The Street, an FMW Media business show production, will air episode 535 on the FOX Business N...
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces its feature lineup for its business show airing on the F...
NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the 530th episode lineup of its national business TV sho...
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock b...
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The com...
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...
News, Short Squeeze, Breakout and More Instantly...
Acurx Pharmaceuticals Inc. Company Name:
ACXP Stock Symbol:
NASDAQ Market:
Acurx Pharmaceuticals Inc. Website:
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the broadcasting of its national business TV show airing on Bloomberg TV as sponsored programming tonight, Thursday, June 6, 2024, at 9:30 PM PT. New to The Street's TV episode 576 will air the follo...
Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection PR Newswire Agreement with FDA reached on key elements to move forward with our international Phase 3 clinical trial program Agreement al...
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , May 15, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical stage biophar...